The MSM Corporation International Ltd (ASX: MSM) share price is rocketing higher today. This comes after the company announced strong customer uptake to the launch of the newly released Zombie Rollerz: Pinball Heroes on Apple Arcade.
At the time of writing, the MSM share price is up by 8.6% to 5 cents per share. In comparison, the All Ordinaries Index (ASX: XAO) is up 0.6% to 6,962 points.
Stardom launch
The company has been in the spotlight with investors, with the MSM share price soaring 20% in the last 2 days alone.
According to the release, MSM advised that Zombie Rollerz: Pinball Heroes has generated a lot of interest. The game, co-developed by Zing Games and MSM's strategic partner, Firefly Games Inc. was launched globally 3 days ago.
Since then, statistics gathered from Apple (NASDAQ: AAPL) have recorded 30 million impressions, over 325,000 page views, and first day retention at 45%. Management stated that the result has far exceeded its expectations.
Last month, MSM acquired a 10% stake in Riva Technology and Entertainment Limited (RTE) group. RTE is the majority shareholder in another company that is the sole owner of Firefly Games. Through this investment, MSM has a priority right to be paid in profits or distributions received by RTE, including gaming revenues.
Management commentary
MSM chair Mr Antoine Massad commented on the strong rollout of Zombie Rollerz:
For Zombie Rollerz to be featured as Game of the Day on the Apple Arcade App Store is a fantastic achievement given that it is a game developed entirely during the COVID-19 pandemic.
It is a credit to all involved and reiterates the benefit of our strategic relationship with RTE as they seek to maximise user engagement and monetisation opportunities in the rapidly evolving gaming industry.
MSM share price summary
The MSM share price has been on fire lately, with shareholders seeing gains of more than 20% during the week. While its shares were most stagnant from July, recent tailwinds have created investor hype.
Today's share price increase represents a 1000% return for patient shareholders who kept their holdings since March.
